NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/26/2025
Back to search
Official data from USPTO
GENEOS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENEOS THERAPEUTICS
ST13
US500000087289084Class
42
Filing
87289084
Registration
6119258
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
11/27/2025
Trademark type
Word
Nice classes
42
Filing date
01/04/2017
Registration date
08/04/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2025
Last transaction
11/27/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/12/2019
First use in commerce
02/12/2019
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
LAPTER,ALAIN J
Current location
Historical data usage
Holders and representatives
Holders
GENEOS THERAPEUTICS, INC.
GENEOS THERAPEUTICS, INC.
Inovio Pharmaceuticals, Inc.
Representatives
Muzamil Huq Morrison & Foerster LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the fields of pharmaceuticalsbiopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific researchconducting clinical trials for others; Research and development of treatments for infectious diseases
Publications
History of USPTO decisions and trademark events.
52 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/26/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/12/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/27/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/26/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/24/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/24/2020
IUAF
USE AMENDMENT FILED
06/05/2020
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/21/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/20/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/13/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/02/2020
EX4G
SOU EXTENSION 4 GRANTED
12/31/2019
EXT4
SOU EXTENSION 4 FILED
12/31/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/31/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2019
EX3G
SOU EXTENSION 3 GRANTED
05/30/2019
EXT3
SOU EXTENSION 3 FILED
05/30/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/30/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/07/2018
EX2G
SOU EXTENSION 2 GRANTED
12/05/2018
EXT2
SOU EXTENSION 2 FILED
12/05/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/04/2018
EX1G
SOU EXTENSION 1 GRANTED
07/02/2018
EXT1
SOU EXTENSION 1 FILED
07/02/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/02/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/26/2017
ALIE
ASSIGNED TO LIE
09/22/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/10/2017
GNSL
LETTER OF SUSPENSION E-MAILED
03/10/2017
CNSL
SUSPENSION LETTER WRITTEN
03/10/2017
DOCK
ASSIGNED TO EXAMINER
03/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2017
NWAP
NEW APPLICATION ENTERED
01/07/2017
Continuous trademark protection
Get notified about every new filing that threatens GENEOS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.